###begin article-title 0
###xml 49 73 49 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Streptococcus pneumoniae</italic>
###xml 49 73 <span type="species:ncbi:1313">Streptococcus pneumoniae</span>
Increased Susceptibility for Superinfection with Streptococcus pneumoniae during Influenza Virus Infection Is Not Caused by TLR7-Mediated Lymphopenia
###end article-title 0
###begin p 1
Conceived and designed the experiments: MG. Performed the experiments: SS SD AK MG. Analyzed the data: SS SD AK MG DB. Contributed reagents/materials/analysis tools: DB. Wrote the paper: BHN MG. Supervised experiments: DB BHN.
###end p 1
###begin p 2
###xml 423 447 423 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Streptococcus pneumoniae</italic>
###xml 783 796 783 796 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pneumoniae</italic>
###xml 0 17 <span type="species:ncbi:11320">Influenza A virus</span>
###xml 19 22 <span type="species:ncbi:11320">IAV</span>
###xml 155 158 <span type="species:ncbi:11320">IAV</span>
###xml 301 304 <span type="species:ncbi:11320">IAV</span>
###xml 359 362 <span type="species:ncbi:11320">IAV</span>
###xml 423 447 <span type="species:ncbi:1313">Streptococcus pneumoniae</span>
###xml 636 640 <span type="species:ncbi:10090">mice</span>
###xml 670 673 <span type="species:ncbi:11320">IAV</span>
###xml 783 796 <span type="species:ncbi:1313">S. pneumoniae</span>
###xml 830 833 <span type="species:ncbi:11320">IAV</span>
###xml 959 963 <span type="species:ncbi:10090">mice</span>
###xml 969 972 <span type="species:ncbi:11320">IAV</span>
Influenza A virus (IAV) causes respiratory tract infections leading to recurring epidemics with high rates of morbidity and mortality. In the past century IAV induced several world-wide pandemics, the most aggressive occurring in 1918 with a death toll of 20-50 million cases. However, infection with IAV alone is rarely fatal. Instead, death associated with IAV is usually mediated by superinfection with bacteria, mainly Streptococcus pneumoniae. The reasons for this increased susceptibility to bacterial superinfection have not been fully elucidated. We previously demonstrated that triggering of TLR7 causes immune incompetence in mice by induction of lymphopenia. IAV is recognized by TLR7 and infections can lead to lymphopenia. Since lymphocytes are critical to protect from S. pneumoniae it has long been speculated that IAV-induced lymphopenia might mediate increased susceptibility to superinfection. Here we show that sub-lethal pre-infections of mice with IAV-PR8/A/34 strongly increased their mortality in non-lethal SP infections, surprisingly despite the absence of detectable lymphopenia. In contrast to SP-infection alone co-infected animals were unable to control the exponential growth of SP. However, lymphopenia forced by TLR7-triggering or antibody-mediated neutropenia did not increase SP-susceptibility or compromise the ability to control SP growth. Thus, the immune-incompetence caused by transient lympho- or leukopenia is not sufficient to inhibit potent antibacterial responses of the host and mechanisms distinct from leukodepletion must account for increased bacterial superinfection during viral defence.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 65 68 65 68 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-Doherty1">[1]</xref>
###xml 70 73 70 73 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-Subbarao1">[2]</xref>
###xml 170 173 170 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-Subbarao1">[2]</xref>
###xml 198 201 198 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-Taubenberger1">[3]</xref>
###xml 333 336 333 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-Taubenberger2">[4]</xref>
###xml 338 341 338 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-Tumpey1">[5]</xref>
###xml 474 477 474 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-Taubenberger1">[3]</xref>
###xml 479 482 479 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-GarciaSastre1">[6]</xref>
###xml 0 17 <span type="species:ncbi:11320">Influenza A virus</span>
###xml 19 22 <span type="species:ncbi:11320">IAV</span>
###xml 235 238 <span type="species:ncbi:11320">IAV</span>
###xml 321 324 <span type="species:ncbi:11320">IAV</span>
Influenza A virus (IAV) belongs to the class of orthomyxoviridae [1], [2] and presents with high genetic variability which is the cause for regularly occurring epidemics [2] or world-wide pandemics [3]. The 20th century has seen three IAV-pandemics, the most aggressive one being the "Spanish Flu" of 1918/1919. The 1918 IAV-variant [4], [5] rapidly spread over the globe reaching the most remote places such as Spitzbergen or Alaska causing 20-50 million deaths world-wide [3], [6].
###end p 4
###begin p 5
###xml 139 163 139 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Streptococcus pneumoniae</italic>
###xml 163 166 163 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-McCullers1">[7]</xref>
###xml 168 171 168 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-Morens1">[8]</xref>
###xml 217 230 217 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pneumoniae</italic>
###xml 276 279 276 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-Madhi1">[9]</xref>
###xml 353 366 353 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pneumoniae</italic>
###xml 366 369 366 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-McCullers1">[7]</xref>
###xml 371 375 371 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-McCullers2">[10]</xref>
###xml 377 390 377 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pneumoniae</italic>
###xml 459 463 459 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-Kadioglu1">[11]</xref>
###xml 715 719 715 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-Kadioglu1">[11]</xref>
###xml 720 724 720 724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-Balakrishnan1">[13]</xref>
###xml 965 968 965 968 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-Madhi1">[9]</xref>
###xml 970 974 970 974 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-Kadioglu2">[14]</xref>
###xml 1062 1066 1062 1066 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-Kadioglu1">[11]</xref>
###xml 1068 1072 1068 1072 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-Paterson1">[15]</xref>
###xml 1074 1078 1074 1078 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-Kadioglu3">[16]</xref>
###xml 54 57 <span type="species:ncbi:11320">IAV</span>
###xml 139 163 <span type="species:ncbi:1313">Streptococcus pneumoniae</span>
###xml 217 230 <span type="species:ncbi:1313">S. pneumoniae</span>
###xml 250 253 <span type="species:ncbi:11320">IAV</span>
###xml 345 348 <span type="species:ncbi:11320">IAV</span>
###xml 353 366 <span type="species:ncbi:1313">S. pneumoniae</span>
###xml 377 390 <span type="species:ncbi:1313">S. pneumoniae</span>
###xml 678 686 <span type="species:ncbi:9606">patients</span>
The major reason for this large mortality was not the IAV-infection per se but rather secondary bacterial superinfections, often caused by Streptococcus pneumoniae[7], [8]. Supporting this notion, vaccination against S. pneumoniae can prevent 31% of IAV-associated pneumonias [9]. Thus, there seems to be a particularly lethal synergism between IAV and S. pneumoniae[7], [10]. S. pneumoniae is a Gram-positive, encapsulated, facultatively anaerobic bacterium [11] that is considered the most common bacterial respiratory tract pathogen. It causes otitis media and sinusitis, but is also a major contributor to community acquired pneumonia with mortality rates as high as 20% in patients with concurrent septicaemia [11]-[13]. The natural host-defence comprises complement-mediated phagocytosis and killing by polymorphonuclear neutrophil granulocytes (PMN). Serotype-specific antibodies of the host aid in this process and form the basis for preventive vaccination [9], [14]. Recently also CD4+ T cells have been implicated in the early control of the infection [11], [15], [16].
###end p 5
###begin p 6
###xml 111 114 111 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-McCullers1">[7]</xref>
###xml 271 274 271 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-McCullers1">[7]</xref>
###xml 487 491 487 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-McCullers2">[10]</xref>
###xml 593 597 593 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-McCullers2">[10]</xref>
###xml 798 801 798 801 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-McCullers1">[7]</xref>
###xml 803 807 803 807 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-Speshock1">[17]</xref>
###xml 975 979 975 979 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-Didierlaurent1">[18]</xref>
###xml 1237 1241 1237 1241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-Didierlaurent1">[18]</xref>
###xml 9 12 <span type="species:ncbi:11320">IAV</span>
###xml 370 373 <span type="species:ncbi:11320">IAV</span>
###xml 536 539 <span type="species:ncbi:11320">IAV</span>
###xml 581 586 <span type="species:ncbi:10090">mouse</span>
###xml 704 707 <span type="species:ncbi:11320">IAV</span>
###xml 934 938 <span type="species:ncbi:10090">mice</span>
###xml 971 974 <span type="species:ncbi:11320">IAV</span>
###xml 1059 1062 <span type="species:ncbi:11320">IAV</span>
###xml 1072 1076 <span type="species:ncbi:10090">mice</span>
Although IAV-mediated predisposition for bacterial superinfections was initially observed almost 200 years ago [7] the molecular and cellular mechanisms for this lethal synergism are still not fully elucidated. A number of explanations exist (comprehensively reviewed in [7]). The most widely used concept is focussed on the destruction of the respiratory epithelium by IAV allowing increased adhesion of bacteria to the tracheal wall and thus better retention and growth of pneumococci [10]. However, also less destructive variants of IAV are able to induce lethal synergism in a mouse model [10] arguing for additional mechanisms. E.g. a massive induction of pro-inflammatory cytokines was observed in IAV-infected animals recruiting large numbers of PMN which ultimately destroy the lung tissue [7], [17]. However, other groups could demonstrate the opposite, a strongly reduced recruitment of PMN during pneumococcal infection in mice 4-6 weeks after recovering from IAV [18]. This was associated with a decreased response of alveolar macrophages (AM) in IAV-infected mice in response to Toll-like receptor (TLR) ligands of bacterial origin leading to their inability to produce neutrophil attracting chemokines such as Mip-2 and KC [18]. The latter study, however, fails to explain why a natural mechanism should exist that renders animals highly susceptible to secondary bacterial infections for several weeks after a single viral infection. It is difficult to imagine how such a process should have survived through evolution in the presence of a constant bacterial threat.
###end p 6
###begin p 7
###xml 487 491 483 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-Sun1">[19]</xref>
###xml 559 572 555 568 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pneumoniae</italic>
###xml 579 583 575 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-Paterson1">[15]</xref>
###xml 368 371 <span type="species:ncbi:11320">IAV</span>
###xml 559 572 <span type="species:ncbi:1313">S. pneumoniae</span>
It seems more conceivable that immediate mechanisms directly associated with the viral defence process might be responsible for the increased susceptibility to bacterial superinfection during ongoing antiviral action and not after successful viral depletion. Along those lines it has been demonstrated, that impairment in AM phagocytosis of pneumococci 8-9 days after IAV infection was dependent on the reduction of the scavenger receptor MARCO on AM via T cell-derived interferon gamma [19]. MARCO is one of the major receptors responsible for the uptake of S. pneumoniae by AM [15].
###end p 7
###begin p 8
###xml 234 238 230 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-Tumpey2">[20]</xref>
###xml 239 243 235 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-Navarini1">[22]</xref>
###xml 331 353 327 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Listeria monocytogenes</italic>
###xml 506 510 502 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-Navarini1">[22]</xref>
###xml 303 307 <span type="species:ncbi:10090">mice</span>
###xml 331 353 <span type="species:ncbi:1639">Listeria monocytogenes</span>
###xml 360 364 <span type="species:ncbi:11623?0.9953846153846154">LCMV</span>
While massive production of T cell-derived interferon gamma is clearly a hallmark of antiviral immune responses, also another change in virally infected hosts is frequently observed, which is leukopenia mediated by type 1 interferons [20]-[22]. Indeed it has been shown that increased susceptibility of mice to superinfection with Listeria monocytogenes after LCMV infection is caused by enhanced apoptosis of PMN leading to leukopenia and drastically reduced PMN infiltration at bacterial infection sites [22].
###end p 8
###begin p 9
###xml 212 216 212 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-Diebold1">[23]</xref>
###xml 217 221 217 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-Pichlmair1">[25]</xref>
###xml 466 470 466 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-Gunzer1">[26]</xref>
###xml 549 553 549 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-Gunzer1">[26]</xref>
###xml 605 609 605 609 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-Tumpey2">[20]</xref>
###xml 656 669 656 669 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pneumoniae</italic>
###xml 801 805 801 805 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-McCullers2">[10]</xref>
###xml 884 888 884 888 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-Tumpey2">[20]</xref>
###xml 94 97 <span type="species:ncbi:11320">IAV</span>
###xml 135 138 <span type="species:ncbi:11320">IAV</span>
###xml 441 445 <span type="species:ncbi:10090">mice</span>
###xml 560 563 <span type="species:ncbi:11320">IAV</span>
###xml 648 651 <span type="species:ncbi:11320">IAV</span>
###xml 656 669 <span type="species:ncbi:1313">S. pneumoniae</span>
###xml 783 786 <span type="species:ncbi:11320">IAV</span>
###xml 870 873 <span type="species:ncbi:11320">IAV</span>
Is it possible, that similar mechanisms underlie the increased pneumococcal superinfection of IAV infected hosts? The host response to IAV is initiated by TLR7- and RIG-I-mediated recognition of the viral genome [23]-[25] leading to a rapid and massive production of type I interferons which are able to establish a so-called antiviral state. We have shown that triggering of TLR7 by the specific ligand R-848 rapidly induces lymphopenia in mice lasting 36-48 hours [26]. This lymphopenia renders animals unable to mount peripheral immune responses [26]. Also IAV infections can cause massive lymphopenia [20] peaking at day 7 of the infection. In IAV and S. pneumoniae co-infection models the time point of highest susceptibility for the bacterial superinfection was at day 7 after IAV pre-infection [10], correlating precisely with the peak of lymphopenia seen during IAV infection [20]. Thus we reasoned that TLR7 induced lymphopenia might increase susceptibility to pneumococcal superinfection.
###end p 9
###begin p 10
###xml 100 104 100 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-McCullers2">[10]</xref>
###xml 122 135 122 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pneumoniae</italic>
###xml 149 153 149 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-Tettelin1">[27]</xref>
###xml 155 159 155 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-Sandgren1">[28]</xref>
###xml 454 467 454 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pneumoniae</italic>
###xml 30 35 <span type="species:ncbi:10090">mouse</span>
###xml 66 71 <span type="species:ncbi:10090">mouse</span>
###xml 80 83 <span type="species:ncbi:11320">IAV</span>
###xml 122 135 <span type="species:ncbi:1313">S. pneumoniae</span>
###xml 414 418 <span type="species:ncbi:10090">mice</span>
###xml 454 467 <span type="species:ncbi:1313">S. pneumoniae</span>
To test this we established a mouse model for co-infection of the mouse adapted IAV-strain PR8/A/34 [10] and the invasive S. pneumoniae strain TIGR4 [27], [28]. Individually, both infections were sublethal but showed strong synergistic action when combined. Here we demonstrate that peripheral lymphocyte-counts were not diminished in this model and also that forced depletion of lymphocytes or PMN did not render mice susceptible to superinfection with S. pneumoniae.
###end p 10
###begin title 11
Methods
###end title 11
###begin title 12
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice
###end title 12
###begin p 13
###xml 15 19 <span type="species:ncbi:10090">mice</span>
###xml 142 146 <span type="species:ncbi:10090">Mice</span>
Female C57Bl/6 mice were purchased from Charles River (Sulzfeld, Germany) or Harlan Winkelmann (Borchen, Germany) at the age of 6 to 8 weeks. Mice were housed under specific pathogen-free conditions according to the guidelines of the regional animal care committee. All experiments were approved by the local ethical committees (for the HZI: Niedersachsisches Landesamt fur Verbraucherschutz und Lebensmittelsicherheit, file number 33.42502-006/07 and for the KI: all the experiments were conducted in conformity with the European Communities Council Directive 86/609/EEC and the Swedish animal protection legislation.)
###end p 13
###begin title 14
Viral and bacterial pathogens
###end title 14
###begin p 15
###xml 34 38 34 38 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-McCullers2">[10]</xref>
###xml 173 174 167 168 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 430 454 424 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Streptococcus pneumoniae</italic>
###xml 513 517 507 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-Tettelin1">[27]</xref>
###xml 519 523 513 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-Sandgren1">[28]</xref>
###xml 668 669 656 657 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 841 845 829 833 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-Lacks1">[29]</xref>
###xml 888 891 876 879 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">620</sub>
###xml 0 17 <span type="species:ncbi:11320">Influenza A virus</span>
###xml 265 270 <span type="species:ncbi:10090">mouse</span>
###xml 430 460 <span type="species:ncbi:170187">Streptococcus pneumoniae TIGR4</span>
###xml 613 618 <span type="species:ncbi:9940">sheep</span>
###xml 827 832 <span type="species:ncbi:4932">yeast</span>
###xml 996 1001 <span type="species:ncbi:10090">mouse</span>
Influenza A virus PR8/A/34 (H1N1) [10] was grown on Madin-Darby canine kidney (MDCK) cells. Shortly, cells were infected with the virus and incubated at 35degreesC and 5% CO2 for 24 hours. Supernatant was harvested, spun down to remove cellular debris and used for mouse infection experiments. Supernatant from uninfected cells was obtained likewise and served as inoculum for uninfected control animals. For bacterial challenges Streptococcus pneumoniae TIGR4, an encapsulated strain of serotype 4 (ATCC BAA-334 [27], [28]), was grown overnight on blood agar plates (BD Diagnostic Systems, Columbia Agar with 5% sheep blood) from frozen stocks at 37degreesC and 5% CO2. Colonies were briefly inoculated into pre-warmed DS (dextrose- serum) medium (OXOID manual 1990), and then inoculated into pre- warmed C+Y (casamino acid & yeast extract [29]) medium, grown to midlogarithmic phase (OD620 = 0,5) and subsequently diluted in C+Y medium in order to obtain the appropriate concentrations for the mouse infections. Bacterial medium was produced by the Karolinska Microbiology Laboratory (Solna, Sweden).
###end p 15
###begin title 16
R-848 treatment
###end title 16
###begin p 17
###xml 217 221 205 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-Gunzer1">[26]</xref>
###xml 198 203 <span type="species:ncbi:10090">mouse</span>
For systemic TLR7 triggering, R-848 (Axxora, Loerrach/Germany) was administered intraperitoneally in a volume of 100 microl PBS at a concentration of 25 microg/ml, resulting in a dose of 2,5 microg/mouse as described [26].
###end p 17
###begin title 18
RB6-8C5 antibody treatment
###end title 18
###begin p 19
###xml 210 223 202 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pneumoniae</italic>
###xml 88 93 <span type="species:ncbi:10090">mouse</span>
###xml 210 223 <span type="species:ncbi:1313">S. pneumoniae</span>
###xml 300 303 <span type="species:ncbi:10116">rat</span>
For PMN depletion experiments 100 microg of the monoclonal antibody RB6-8C5 recognizing mouse Ly-6G (Gr-1, BioXCell, West Lebanon/USA) was intraperitoneally injected in a volume of 100 microl PBS 24 h prior to S. pneumoniae infection. Control animals were likewise treated with 100 microg of control rat IgG (Sigma-Aldrich). To confirm PNM depletion, at different time points after injection, 30 microl blood were taken from the tail vein, the sample depleted of erythrocytes as described below, cells stained with Phyco-erythrin labelled RB6-8C5 and analysed using a BD FACSCalibur or FACSCanto flow cytometer and the Dako Summit software.
###end p 19
###begin title 20
Viral and bacterial infections
###end title 20
###begin p 21
###xml 51 55 <span type="species:ncbi:10090">mice</span>
###xml 221 226 <span type="species:ncbi:10090">mouse</span>
For viral and bacterial challenge, 7 to 9 week old mice were lightly anaesthetized by isofluorane inhalation. Holding the animals upright, the viral or bacterial inoculum was given onto the nostrils to be taken up by the mouse upon breathing.
###end p 21
###begin p 22
###xml 104 106 104 106 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 156 160 156 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-Reed1">[30]</xref>
###xml 379 381 375 377 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 583 585 579 581 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 26 29 <span type="species:ncbi:11320">IAV</span>
###xml 96 100 <span type="species:ncbi:10090">mice</span>
###xml 181 185 <span type="species:ncbi:10090">mice</span>
###xml 418 422 <span type="species:ncbi:10090">Mice</span>
###xml 548 553 <span type="species:ncbi:10090">mouse</span>
For the MDCK-cell derived IAV PR8/A/34 virus stock the dose lethal to 50% of inoculated C57Bl/6 mice (LD50) was determined by the method of Reed and Muench [30]. Briefly, groups of mice were intranasally infected with 25 microl of appropriate dilutions of the virus stock in control medium. Body weight and health status were monitored, survival assessed over 14 days and the MLD50 determined by endpoint calculation. Mice having lost more than 25% of body weight were sacrificed and the infection considered lethal. For all following experimental mouse infections a dose of 0.04 MLD50 was chosen.
###end p 22
###begin p 23
###xml 4 17 4 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pneumoniae</italic>
###xml 110 111 98 99 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 4 23 <span type="species:ncbi:170187">S. pneumoniae TIGR4</span>
###xml 186 190 <span type="species:ncbi:10090">Mice</span>
For S. pneumoniae TIGR4 challenge, bacteria were diluted in C+Y medium to a concentration of approximately5x106 CFU/ml, verified by plating out 10-fold dilutions onto blood-agar plates. Mice were inoculated intranasally with 20 microl of bacterial solution (controls with medium alone), health status was monitored at least twice/day for seven days or until earlier sacrificing. Blood was analyzed for bacterial counts at 24, 48 and 72 h after infection. When observing impairment in health conditions animals were sacrificed and the infection regarded as lethal.
###end p 23
###begin title 24
###xml 14 27 14 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pneumoniae</italic>
###xml 14 27 <span type="species:ncbi:1313">S. pneumoniae</span>
Assessment of S. pneumoniae CFU counts in blood, lungs, tracheal and bronchoalveolar lavage
###end title 24
###begin p 25
For the assessment of bacterial counts in blood, 5 microl of blood were taken from the tail vein, serially diluted in PBS and dilutions were plated onto blood agar.
###end p 25
###begin p 26
###xml 51 55 <span type="species:ncbi:10090">mice</span>
For CFU counts in lung tissue, lungs of sacrificed mice were aseptically removed, collected in 1 ml of PBS, homogenized through a 100 microm cell strainer and serial dilutions in PBS plated on blood plates.
###end p 26
###begin p 27
Nasopharyngeal lavage was obtained post mortem by flushing the nasopharynx through trachea and nares with PBS through a 20G canule inserted into the trachea. 100 microl of fluid were collected from the nares and used for plating serial dilutions on blood plates.
###end p 27
###begin p 28
###xml 251 252 245 246 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Bronchoalveolar lavage was collected by flushing the lungs once with 1 ml of PBS. To determine CFU counts the sample was serially diluted in PBS and plated on blood plates. CFUs on blood plates were counted after 16 h of incubation at 37degreesC/5% CO2.
###end p 28
###begin title 29
Quantification of peripheral blood lymphocytes
###end title 29
###begin p 30
###xml 452 453 448 449 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 468 469 464 465 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 575 576 571 572 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 582 583 578 579 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 598 599 594 595 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 84 87 <span type="species:ncbi:11320">IAV</span>
###xml 97 101 <span type="species:ncbi:10090">mice</span>
###xml 318 321 <span type="species:ncbi:11320">IAV</span>
For the quantification of peripheral blood lymphocytes from either R-848 treated or IAV infected mice, the animals were bled by tail vein puncture. Blood samples of defined volume (30 microl blood) were obtained before, 1 hour, 24 hours and 48 hours after R-848 injection or once/day at the indicated time points post IAV infection. Blood samples were depleted of erythrocytes by osmotic shock through addition of red blood cell lysis buffer (0.15 M NH4Cl, 0.01 M KHCO3, 0.1 mM EDTA, pH7.2) and subsequent centrifugation to pellet lymphocytes. Cells were then stained for CD4+, CD8a+ and CD45R/B220+ (antibodies from BD Pharmingen, clone RM 4-5, 53-6.7 and RA3-6B2, respectively). Cell counts were acquired on BD FACSCanto or FACSCalibur flow cytometers. Acquisition of a defined volume was performed by analysing samples at a constant flow rate over a defined period of time. This allowed tracking of cell counts over various time points, expressing cell numbers as percentage of the starting value at time point 0. Data was analysed using the Dako Summit software.
###end p 30
###begin title 31
Analysis of lymphocyte subsets in lung tissue and bronchoalveolar lavage
###end title 31
###begin p 32
###xml 255 259 <span type="species:ncbi:9913">calf</span>
###xml 613 618 <span type="species:ncbi:10090">mouse</span>
###xml 679 684 <span type="species:ncbi:10090">mouse</span>
Lungs were perfused with PBS, excised and finely minced on ice, followed by enzymatic digestion for 45 minutes at 37degreesC in Iscove's modified Dulbecco's medium (IMDM) containing 0,2 mg/ml Collagenase D (Roche), 10 microg/ml DNase (Sigma) and 5% fetal calf serum. After addition of EDTA (5 mM final concentration), suspensions were pelleted by centrifugation and depleted of erythrocytes by osmotic shock. Cells from BAL fluid were prepared by flushing the lung once with 1 ml PBS and centrifugation of the sample at 420xg for 10 minutes. For FACS analysis, Fc-block was performed through incubation with anti-mouse CD16/CD36 antibody (BD Pharmingen) followed by staining for mouse CD4, CD8, CD19, CD11b and Gr-1 (clones RM4-5, 53-6.7, 1D3, M1/70 and RB6-8C5, respectively). Data were acquired on a BD FACS Canto flow cytometer and analysed using DAKO Summit software.
###end p 32
###begin title 33
Statistical analysis
###end title 33
###begin p 34
###xml 68 69 68 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
All statistical analyses shown were performed by paired, two-tailed t test and survival data compared by Kaplan Meier analysis log rank test using Graph Pad Prism software (Graph Pad Software, La Jolla/USA).
###end p 34
###begin title 35
Results
###end title 35
###begin title 36
###xml 27 40 27 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pneumoniae</italic>
###xml 23 26 <span type="species:ncbi:11320">IAV</span>
###xml 27 40 <span type="species:ncbi:1313">S. pneumoniae</span>
Characterization of an IAV/S. pneumoniae co-infection model
###end title 36
###begin p 37
###xml 36 49 36 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pneumoniae</italic>
###xml 207 209 207 209 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 365 372 365 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004840-g001">Fig. 1A</xref>
###xml 407 420 407 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pneumoniae</italic>
###xml 462 463 462 463 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 531 538 531 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004840-g001">Fig. 1A</xref>
###xml 644 651 644 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004840-g001">Fig. 1B</xref>
###xml 734 747 734 747 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pneumoniae</italic>
###xml 847 851 847 851 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-McCullers2">[10]</xref>
###xml 908 921 908 921 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pneumoniae</italic>
###xml 1034 1041 1034 1041 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004840-g001">Fig. 1C</xref>
###xml 1231 1238 1231 1238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004840-g001">Fig. 1D</xref>
###xml 32 35 <span type="species:ncbi:11320">IAV</span>
###xml 36 49 <span type="species:ncbi:1313">S. pneumoniae</span>
###xml 67 72 <span type="species:ncbi:10090">mouse</span>
###xml 129 134 <span type="species:ncbi:10090">mouse</span>
###xml 213 216 <span type="species:ncbi:11320">IAV</span>
###xml 407 420 <span type="species:ncbi:1313">S. pneumoniae</span>
###xml 721 724 <span type="species:ncbi:11320">IAV</span>
###xml 734 747 <span type="species:ncbi:1313">S. pneumoniae</span>
###xml 892 895 <span type="species:ncbi:11320">IAV</span>
###xml 908 921 <span type="species:ncbi:1313">S. pneumoniae</span>
To establish a model system for IAV/S. pneumoniae synergism in the mouse we established two sublethal infections with either the mouse-adapted viral strain PR8/A/34 or the pneumococcal strain TIGR4. 0.04 MLD50 of IAV caused a mild disease with a transient mean loss of max. 10% body weight up to day 7 of the infection, which was resolved by day 12 post infection (Fig. 1A). Likewise, a sublethal course of S. pneumoniae was established after infection with 1x105 CFU that was not detectable by weight changes of infected animals (Fig. 1A). A productive infection was verified from nasopharyngeal lavages at day 7 p.i. in all infected animals (Fig. 1B). Survival-curves showed that both infections were sublethal to 80% (IAV) or 88% (S. pneumoniae) of all animals although single individuals could still succumb to the infection as seen elsewhere [10]. The combined sublethal infections with IAV followed by S. pneumoniae 7 days later were highly synergistic leading to 63% mortality within 2 days after the bacterial superinfection (Fig. 1C). The lung homogenates of animals succumbing to the co-infection showed high CFU in their tissues similar to the levels observed in the rare cases of lethal courses from single infections (Fig. 1D).
###end p 37
###begin title 38
###xml 69 93 69 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Streptococcus pneumoniae</italic>
###xml 0 17 <span type="species:ncbi:11320">Influenza A virus</span>
###xml 69 93 <span type="species:ncbi:1313">Streptococcus pneumoniae</span>
Influenza A virus infection predisposes for invasive disease through Streptococcus pneumoniae.
###end title 38
###begin p 39
###xml 67 69 67 69 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 110 111 110 111 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 116 140 116 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Streptococcus pneumoniae</italic>
###xml 234 247 234 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pneumoniae</italic>
###xml 413 426 413 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pneumoniae</italic>
###xml 447 460 447 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pneumoniae</italic>
###xml 533 546 533 546 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pneumoniae</italic>
###xml 12 16 <span type="species:ncbi:10090">mice</span>
###xml 70 87 <span type="species:ncbi:11320">Influenza A virus</span>
###xml 89 92 <span type="species:ncbi:11320">IAV</span>
###xml 116 146 <span type="species:ncbi:170187">Streptococcus pneumoniae TIGR4</span>
###xml 148 150 <span type="species:ncbi:170187">T4</span>
###xml 234 247 <span type="species:ncbi:1313">S. pneumoniae</span>
###xml 354 358 <span type="species:ncbi:10090">mice</span>
###xml 385 388 <span type="species:ncbi:11320">IAV</span>
###xml 413 426 <span type="species:ncbi:1313">S. pneumoniae</span>
###xml 427 429 <span type="species:ncbi:170187">T4</span>
###xml 447 460 <span type="species:ncbi:1313">S. pneumoniae</span>
###xml 461 463 <span type="species:ncbi:170187">T4</span>
###xml 482 485 <span type="species:ncbi:11320">IAV</span>
###xml 533 546 <span type="species:ncbi:1313">S. pneumoniae</span>
###xml 565 582 <span type="species:ncbi:11320">Influenza A virus</span>
###xml 604 608 <span type="species:ncbi:10090">mice</span>
###xml 735 739 <span type="species:ncbi:10090">mice</span>
###xml 787 791 <span type="species:ncbi:10090">mice</span>
(A) C57Bl/6 mice were intranasally inoculated with medium, 0.04 MLD50 Influenza A virus (IAV) PR8/A/34 or 1x105 CFU Streptococcus pneumoniae TIGR4 (T4) and weighed daily. Body weight is shown as % relative to the starting weight. (B) S. pneumoniae CFU counts in tracheal lavage of survivors seven days after i.n. infection. (C) Survival rates of C57Bl/6 mice after i.n. infection with IAV PR8/A/34 alone (day 0), S. pneumoniae T4 alone (day 7) or S. pneumoniae T4 (day 7) following IAV (day 0). (D) CFU counts in lung homogenates of S. pneumoniae only infected and Influenza A virus pre-infected C57Bl/6 mice in which infection was lethal. All data shown are compiled from at least two independent experiments with groups of 5 or more mice. No bacteria could be detected in the lungs of mice surviving the infections (not shown).
###end p 39
###begin p 40
###xml 83 96 83 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pneumoniae</italic>
###xml 267 273 267 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004840-g002">Fig. 2</xref>
###xml 592 598 592 598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004840-g002">Fig. 2</xref>
###xml 83 96 <span type="species:ncbi:1313">S. pneumoniae</span>
###xml 401 405 <span type="species:ncbi:10090">mice</span>
###xml 524 528 <span type="species:ncbi:10090">mice</span>
###xml 720 724 <span type="species:ncbi:10090">mice</span>
This suggested the inability to control the bacterial spread as cause for a lethal S. pneumoniae superinfection. Thus, we measured the extent of colonization at defined time points (4 and 24 h) after the bacterial infection either alone or in the co-infection model (Fig. 2). At 4 h p.i. animals in both models could still control bacterial spread to the same degree. However, at 24 h singly infected mice started to clear the bacterial infection in both the bronchoalveolar lavage (BAL) and lung-tissues, while co-infected mice failed to control bacterial proliferation at all sites tested (Fig. 2). These findings further supported that a defect in controlling bacterial growth occurred already early in superinfected mice.
###end p 40
###begin title 41
###xml 59 83 59 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Streptococcus pneumoniae</italic>
###xml 0 17 <span type="species:ncbi:11320">Influenza A virus</span>
###xml 36 40 <span type="species:ncbi:10090">mice</span>
###xml 59 83 <span type="species:ncbi:1313">Streptococcus pneumoniae</span>
Influenza A virus infection renders mice unable to control Streptococcus pneumoniae growth in the upper and lower respiratory tract.
###end title 41
###begin p 42
###xml 56 58 56 58 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 133 134 133 134 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 139 163 139 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Streptococcus pneumoniae</italic>
###xml 242 255 242 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pneumoniae</italic>
###xml 8 12 <span type="species:ncbi:10090">mice</span>
###xml 59 76 <span type="species:ncbi:11320">Influenza A virus</span>
###xml 78 81 <span type="species:ncbi:11320">IAV</span>
###xml 139 169 <span type="species:ncbi:170187">Streptococcus pneumoniae TIGR4</span>
###xml 171 173 <span type="species:ncbi:170187">T4</span>
###xml 176 180 <span type="species:ncbi:10090">Mice</span>
###xml 242 255 <span type="species:ncbi:1313">S. pneumoniae</span>
###xml 395 399 <span type="species:ncbi:10090">mice</span>
C57Bl/6 mice were inoculated with medium (*) or 0.04 MLD50 Influenza A virus (IAV) PR8/A/34 (o) seven days before infection with 1x105 CFU Streptococcus pneumoniae TIGR4 (T4). Mice were sacrificed 4 and 24 hours after bacterial infection and S. pneumoniae CFU counts in nasopharyngeal lavage (A), bronchoalveolar lavage (B) and lung homogenates (C) were assessed. Data show values of individual mice together with group means (horizontal lines) and are compiled from two independent experiments.
###end p 42
###begin title 43
###xml 29 42 29 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pneumoniae</italic>
###xml 25 28 <span type="species:ncbi:11320">IAV</span>
###xml 29 42 <span type="species:ncbi:1313">S. pneumoniae</span>
Absence of leukopenia in IAV/S. pneumoniae co-infected animals
###end title 43
###begin p 44
###xml 169 173 169 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-Tumpey2">[20]</xref>
###xml 451 457 451 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004840-g003">Fig. 3</xref>
###xml 578 584 578 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004840-g003">Fig. 3</xref>
###xml 306 309 <span type="species:ncbi:11320">IAV</span>
###xml 370 373 <span type="species:ncbi:11320">IAV</span>
###xml 520 523 <span type="species:ncbi:11320">IAV</span>
We next asked whether a reduction of peripheral white blood cells (leukopenia) was associated with the course of the viral infection, as had been demonstrated elsewhere [20]. Thus, we measured the levels of peripheral blood B cells as well as CD4 and CD8 T cells at different time points after a sublethal IAV-infection. However, we never observed lymphocyte-numbers in IAV-infected animals that were below the levels found in mock-infected controls (Fig. 3). In fact, from day 7 up to 14 p.i. the lymphocyte-numbers in IAV-infected animals were higher as compared to controls (Fig. 3).
###end p 44
###begin title 45
###xml 85 102 <span type="species:ncbi:11320">Influenza A virus</span>
Analysis of peripheral blood lymphocyte counts shows no lymphopenia in the course of Influenza A virus infection.
###end title 45
###begin p 46
###xml 55 57 55 57 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 8 12 <span type="species:ncbi:10090">mice</span>
###xml 61 78 <span type="species:ncbi:11320">Influenza A virus</span>
###xml 80 83 <span type="species:ncbi:11320">IAV</span>
###xml 446 450 <span type="species:ncbi:10090">mice</span>
C57Bl/6 mice were intranasally inoculated with 0.04 MLD50 of Influenza A virus (IAV PR8/A/34) or medium (control) and repetitive blood samples on all animals were taken on different days p.i. The numbers of B220- (A), CD4- (B) and CD8-positive (C) cells in peripheral blood as determined by flow cytometry are shown as % relative to pre-infection levels. Data show representative results as means+/-s.e.m. of one out of two experiments with five mice per group.
###end p 46
###begin p 47
###xml 13 16 <span type="species:ncbi:11320">IAV</span>
Thus, in the IAV-infection used here no detectable lymphopenia was evident in the animals despite a prominent viral-bacterial synergism. Therefore, the synergism observed here must be based on mechanisms distinct from peripheral lymphocyte-depletion.
###end p 47
###begin title 48
Forced lympho- or neutropenia does not lead to enhanced susceptibility to bacterial superinfection
###end title 48
###begin p 49
###xml 30 43 30 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pneumoniae</italic>
###xml 197 200 197 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-McCullers1">[7]</xref>
###xml 202 206 202 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-Navarini1">[22]</xref>
###xml 374 378 374 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-Gunzer1">[26]</xref>
###xml 488 501 488 501 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pneumoniae</italic>
###xml 538 542 538 542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-Gunzer1">[26]</xref>
###xml 615 622 615 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004840-g004">Fig. 4A</xref>
###xml 645 649 645 649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-Gunzer1">[26]</xref>
###xml 823 830 823 830 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004840-g004">Fig. 4A</xref>
###xml 970 971 970 971 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 976 977 976 977 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 986 987 986 987 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1169 1170 1169 1170 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1175 1176 1175 1176 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1185 1186 1185 1186 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1227 1228 1227 1228 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1264 1271 1264 1271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004840-g004">Fig. 4B</xref>
###xml 1451 1464 1451 1464 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pneumoniae</italic>
###xml 1547 1554 1547 1554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004840-g004">Fig. 4C</xref>
###xml 1571 1578 1571 1578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004840-g004">Fig. 4D</xref>
###xml 30 43 <span type="species:ncbi:1313">S. pneumoniae</span>
###xml 88 93 <span type="species:ncbi:9606">human</span>
###xml 94 102 <span type="species:ncbi:9606">patients</span>
###xml 488 501 <span type="species:ncbi:1313">S. pneumoniae</span>
###xml 533 537 <span type="species:ncbi:10090">mice</span>
###xml 599 603 <span type="species:ncbi:10090">mice</span>
###xml 640 644 <span type="species:ncbi:10090">mice</span>
###xml 1451 1464 <span type="species:ncbi:1313">S. pneumoniae</span>
###xml 1468 1472 <span type="species:ncbi:10090">mice</span>
Can leukopenia predispose for S. pneumoniae superinfection at all? In animal models and human patients virus-induced leukopenia coincides with increased susceptibility to bacterial superinfections [7], [22]. In addition, we have previously shown that TLR7-triggering with the imidazoquinoline R-848 induces lymphopenia and leads to transient immune-incompetence in the host [26]. Thus, using R-848 as trigger we tested whether forced lymphopenia would render animals hyper-susceptible to S. pneumoniae-infection. As shown for BALB/c mice [26], R-848 also induced profound lymphopenia in the C57Bl/6 mice used here (Fig. 4A). Like in BALB/c mice [26] this lymphopenia was evident at 1 h after application of R-848 and lasted for at least 24 h, being more pronounced in the T cell compartment as compared to the B cell pool (Fig. 4A). To verify, that R-848 treatment also affected lymphocyte numbers at the site of infection, we analyzed lung tissue for the content of CD4+, CD8+ and CD19+ cells. Indeed, although these cells only constituted a minor fraction in the analyzed lung tissues, all populations were further reduced by R-848 treatment (24%, 35% and 13% for CD4+, CD8+ and CD19+ cells, respectively). In the case of CD8+ cells this effect was significant (Fig. 4B). However, despite this effective reduction of cell numbers both in the peripheral blood, as well as at the site of infection, we did not observe an increase in susceptibility to S. pneumoniae in mice rendered lymphopenic, either directly at the time of bacterial infection (Fig. 4C) or 12 h later (Fig. 4D).
###end p 49
###begin title 50
###xml 128 152 128 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Streptococcus pneumoniae</italic>
###xml 128 152 <span type="species:ncbi:1313">Streptococcus pneumoniae</span>
###xml 174 178 <span type="species:ncbi:10090">mice</span>
Systemic TLR7 triggering leads to transient peripheral blood lymphopenia but does not cause increased susceptibility for lethal Streptococcus pneumoniae infection in C57Bl/6 mice.
###end title 50
###begin p 51
###xml 458 459 456 457 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 464 465 462 463 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 474 475 472 473 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 644 645 640 641 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 650 674 646 670 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Streptococcus pneumoniae</italic>
###xml 4 8 <span type="species:ncbi:10090">Mice</span>
###xml 601 605 <span type="species:ncbi:10090">mice</span>
###xml 650 680 <span type="species:ncbi:170187">Streptococcus pneumoniae TIGR4</span>
###xml 682 684 <span type="species:ncbi:170187">T4</span>
###xml 811 815 <span type="species:ncbi:10090">mice</span>
###xml 925 929 <span type="species:ncbi:10090">mice</span>
(A) Mice were injected with PBS or R-848 intraperitoneally and bled from the tail vein immediately before, 1, 24 and 48 h after treatment. Samples were analysed for B220-, CD4- and CD8-positive cells by flow cytometry. Cell numbers are expressed as relative % compared to pre-treatment levels. Data show means+/-s.e.m. compiled from three independent experiments. (B) Likewise, lung tissue of R-848- or PBS-treated animals was analysed for the content of CD4+, CD8+ and CD19+ cells 1 h after treatment. Data show means+/-s.e.m. compiled from five individual animals. Additionally, different groups of mice were intranasally inoculated with 1x105 CFU Streptococcus pneumoniae TIGR4 (T4) together with (C) or 12 hours before (D) intraperitoneal R-848 injection and survival was assessed. The lymphopenia in these mice was also verified (not shown). Data show compiled results of two independent experiments performed with five mice per group (*** p<0.001, * p<0.05).
###end p 51
###begin p 52
###xml 74 87 74 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pneumoniae</italic>
###xml 386 392 386 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004840-g005">Fig. 5</xref>
###xml 74 87 <span type="species:ncbi:1313">S. pneumoniae</span>
###xml 97 101 <span type="species:ncbi:10090">mice</span>
###xml 380 384 <span type="species:ncbi:10090">mice</span>
Although TLR7-mediated lymphopenia did not affect the overall survival of S. pneumoniae-infected mice it was still possible that lymphopenia showed more subtle effects on bacterial spread. Thus we analyzed the course of bacterial deletion at three sites. As already indicated by the viability experiments, also the clearance of bacteria was unchanged in normal versus lymphopenic mice (Fig. 5).
###end p 52
###begin title 53
###xml 66 79 66 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pneumoniae</italic>
###xml 66 79 <span type="species:ncbi:1313">S. pneumoniae</span>
Forced lymphopenia does not interfere with bacterial clearance in S. pneumoniae infected hosts.
###end title 53
###begin p 54
###xml 49 50 49 50 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 55 79 55 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Streptococcus pneumoniae</italic>
###xml 207 220 207 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pneumoniae</italic>
###xml 8 12 <span type="species:ncbi:10090">mice</span>
###xml 55 85 <span type="species:ncbi:170187">Streptococcus pneumoniae TIGR4</span>
###xml 161 165 <span type="species:ncbi:10090">Mice</span>
###xml 207 220 <span type="species:ncbi:1313">S. pneumoniae</span>
###xml 360 364 <span type="species:ncbi:10090">mice</span>
C57Bl/6 mice were intranasally infected with 1x105 CFU Streptococcus pneumoniae TIGR4 and at the same time intraperitoneally injected with PBS (*) or R-848 (o). Mice were sacrificed 4 and 24 hours later and S. pneumoniae CFU counts in nasopharyngeal lavage (A), bronchoalveolar lavage (B) and lung homogenates (C) were assessed. Data show values of individual mice together with group means (horizontal lines) and are compiled from two independent experiments.
###end p 54
###begin p 55
###xml 95 99 95 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-Kadioglu1">[11]</xref>
###xml 101 105 101 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-Kadioglu2">[14]</xref>
###xml 226 230 226 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-Didierlaurent1">[18]</xref>
###xml 232 236 232 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-Navarini1">[22]</xref>
###xml 333 337 333 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-Gunzer1">[26]</xref>
###xml 342 349 342 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004840-g004">Fig. 4A</xref>
###xml 423 436 423 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pneumoniae</italic>
###xml 536 540 536 540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-Hestdal1">[31]</xref>
###xml 542 546 542 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-Conlan1">[32]</xref>
###xml 830 837 826 833 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004840-g006">Fig. 6A</xref>
###xml 984 991 980 987 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004840-g006">Fig. 6B</xref>
###xml 1127 1134 1123 1130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004840-g006">Fig. 6C</xref>
###xml 1354 1361 1350 1357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004840-g006">Fig. 6D</xref>
###xml 423 436 <span type="species:ncbi:1313">S. pneumoniae</span>
###xml 525 530 <span type="species:ncbi:10090">mouse</span>
Finally, a critical leukocyte population that is important for early bacterial control are PMN [11], [14]. In other virus-bacteria co-infection models a reduction of PMN-numbers increases susceptibility to bacterial infection [18], [22]. While TLR7-triggering induces lymphopenia it does not equally well deplete PMN from the blood ([26] and Fig. 4A). Thus, a specific depletion of PMN might increase the susceptibility to S. pneumoniae-infection. We depleted PMN by injection of the monoclonal antibody RB6-8C5 specific for mouse Gr-1 [31], [32] one day before infection. As shown by repetitive measurements in individual animals a single i.p. injection of 100 microg RB6-8C5 antibody led to a very rapid (less than 15 minutes) disappearance of PMN from the peripheral blood which was almost complete and lasted at least 5 days (Fig. 6A). Importantly, the same treatment also led to an almost complete loss of PMN in lung tissue or BAL fluid, thus directly at the site of infection (Fig. 6B). Nevertheless, there was no evidence in the treated animals of an increased bacterial burden or clearance-problems at infected sites (Fig. 6C) nor did we find evidence of sepsis (data not shown). These findings were mirrored in the survival course of the experiments where transiently PMN-depleted animals did not show a significantly increased mortality-rate (Fig. 6D).
###end p 55
###begin title 56
###xml 82 95 82 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pneumoniae</italic>
###xml 82 95 <span type="species:ncbi:1313">S. pneumoniae</span>
Antibody mediated depletion of PMN does not interfere with bacterial clearance in S. pneumoniae infected hosts.
###end title 56
###begin p 57
###xml 306 310 306 310 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sub>
###xml 459 463 459 463 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sub>
###xml 469 470 469 470 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 667 668 667 668 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 673 697 673 697 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Streptococcus pneumoniae</italic>
###xml 754 767 754 767 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pneumoniae</italic>
###xml 8 12 <span type="species:ncbi:10090">mice</span>
###xml 50 53 <span type="species:ncbi:10116">rat</span>
###xml 142 147 <span type="species:ncbi:10090">mouse</span>
###xml 626 630 <span type="species:ncbi:10090">mice</span>
###xml 673 703 <span type="species:ncbi:170187">Streptococcus pneumoniae TIGR4</span>
###xml 754 767 <span type="species:ncbi:1313">S. pneumoniae</span>
###xml 875 879 <span type="species:ncbi:10090">mice</span>
###xml 1043 1047 <span type="species:ncbi:10090">mice</span>
###xml 1171 1175 <span type="species:ncbi:10090">mice</span>
###xml 1232 1236 <span type="species:ncbi:10090">mice</span>
C57Bl/6 mice were intraperitoneally injected with rat IgG (*) as control or RB6-8C5 antibody (o) to deplete PMN. To confirm depletion of PMN, mouse peripheral blood samples were FACS analysed for Gr-1 positive cells on days 1, 2, 5, 6 and 7 post RB6-8C5 antibody treatment. Data show the percentage of Gr-1high cells out of the respective total granulocyte population for one representative out of two analysed animals per group (A). Likewise, numbers of Gr-1high/CD11b+ cells (neutrophils) in lung tissue or BAL fluid were analysed by flow cytometry 24 h post antibody treatment (B). On the day following antibody treatment, mice were intranasally infected with 1x105 CFU Streptococcus pneumoniae TIGR4 and sacrificed 24 hours after infection to assess S. pneumoniae CFU counts in nasopharyngeal lavage, bronchoalveolar lavage and lung homogenates (C). Additional groups of mice were treated equally to assess CFU counts in nasopharyngeal lavage seven days following infection (C) and survival rates (D). CFU counts show values of individual mice together with group means (horizontal lines). Data are compiled from two independent experiments with groups of at least 5 mice. For lung and BAL fluid neutrophil numbers, data from 5 mice/group are shown (+/-s.e.m.).
###end p 57
###begin p 58
###xml 133 146 133 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pneumoniae</italic>
###xml 133 146 <span type="species:ncbi:1313">S. pneumoniae</span>
Together, these experiments showed that a forced lympho- or neutropenia did not render hosts more susceptible to superinfection with S. pneumoniae.
###end p 58
###begin title 59
Discussion
###end title 59
###begin p 60
###xml 271 275 271 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-Gunzer1">[26]</xref>
###xml 374 387 374 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pneumoniae</italic>
###xml 511 524 511 524 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pneumoniae</italic>
###xml 662 666 662 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-Sun2">[33]</xref>
###xml 667 671 667 671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-McNamee1">[35]</xref>
###xml 805 809 805 809 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-Navarini1">[22]</xref>
###xml 878 891 878 891 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pneumoniae</italic>
###xml 891 895 891 895 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-Kadioglu3">[16]</xref>
###xml 982 986 982 986 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-Kadioglu2">[14]</xref>
###xml 1042 1046 1042 1046 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-Gunzer1">[26]</xref>
###xml 1051 1060 1051 1060 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004840-g004">Fig. 4A/B</xref>
###xml 1088 1092 1088 1092 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-Tumpey2">[20]</xref>
###xml 1242 1255 1242 1255 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pneumoniae</italic>
###xml 216 220 <span type="species:ncbi:10090">mice</span>
###xml 366 369 <span type="species:ncbi:11320">IAV</span>
###xml 374 387 <span type="species:ncbi:1313">S. pneumoniae</span>
###xml 393 396 <span type="species:ncbi:11320">IAV</span>
###xml 511 524 <span type="species:ncbi:1313">S. pneumoniae</span>
###xml 878 891 <span type="species:ncbi:1313">S. pneumoniae</span>
###xml 1073 1076 <span type="species:ncbi:11320">IAV</span>
###xml 1234 1237 <span type="species:ncbi:11320">IAV</span>
###xml 1242 1255 <span type="species:ncbi:1313">S. pneumoniae</span>
In this study we have investigated the role played by peripheral leukocytes in the control of a bacterial infection. Sparked by our observation that the depletion of peripheral lymphocytes by TLR7-triggering renders mice incompetent to mount a peripheral immune response [26] we reasoned that a similar mechanism might be responsible for the well known synergism of IAV and S. pneumoniae with IAV acting like a natural TLR7-ligand in this setting. Clearly, cellular immunity is critical for the defence against S. pneumoniae infection. It is well known that the lack of PMN recruitment to infected lungs can render animals susceptible for pneumococcal infection [33]-[35]. Also in other models of bacterial superinfection during ongoing viral disease, a defect of PMN has been identified as leading cause [22]. Likewise, the absence of CD4 cells increases the susceptibility to S. pneumoniae[16], which is a solid finding, although still difficult to explain on a mechanistic basis [14]. CD4 T cells are efficiently depleted by TLR7-ligands ([26] and Fig. 4A/B) and during IAV-infections [20]. In the light of these facts it was logical to hypothesize, that leukopenia would be a possible cause for the observed synergistic action of IAV and S. pneumoniae, more so, as TLR7 would provide a valuable mechanistic link.
###end p 60
###begin p 61
###xml 116 119 116 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-McCullers1">[7]</xref>
###xml 12 15 <span type="species:ncbi:11320">IAV</span>
Associating IAV-induced leukopenia with increased susceptibility to bacterial superinfection is not a novel concept [7] but still lacked a definitive experimental test. Previous studies on this issue suffered from the lack of examples where both, the time course of peripheral blood leukocyte counts and the susceptibility for bacterial superinfection were followed within the same system. Either one of the parameters was measured separately, but never both simultaneously.
###end p 61
###begin p 62
###xml 307 311 307 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-Sun2">[33]</xref>
###xml 398 404 398 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004840-g006">Fig. 6</xref>
###xml 524 528 524 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-Preston1">[36]</xref>
###xml 529 533 529 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-Gingles1">[38]</xref>
###xml 673 677 673 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-Preston1">[36]</xref>
###xml 817 821 817 821 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-McAuley1">[39]</xref>
###xml 849 850 849 850 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 855 859 855 859 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-McNamee1">[35]</xref>
###xml 971 975 971 975 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-Preston1">[36]</xref>
###xml 142 146 <span type="species:ncbi:10090">mice</span>
###xml 158 163 <span type="species:ncbi:10090">mouse</span>
###xml 244 248 <span type="species:ncbi:10090">mice</span>
###xml 382 386 <span type="species:ncbi:10090">mice</span>
###xml 561 565 <span type="species:ncbi:10090">mice</span>
###xml 887 892 <span type="species:ncbi:10090">mouse</span>
In addition, the different experimental systems varied greatly e.g. in the employed pneumococcal and viral isolates as well as the strains of mice. Different mouse strains react very differently to identical treatments. PMN depletion in BALB/c mice renders them highly susceptible to pneumococcal infection [33], while we did not observe any impact of this treatment on the C57Bl/6 mice used here (Fig. 6). Genetic differences between these strains are also responsible for differences in normal pneumococcal susceptibility [36]-[38] and in this context BALB/c mice might be particularly dependent on the rapid recruitment of PMN to control early pneumococcal infiltration [36]. Another critical issue is the infectious dose of pneumococci. This varied by 5 orders of magnitude between studies from as few as 100 CFU [39] to the very high dose of 107 CFU [35]. As has been demonstrated, mouse strains differ enormously in their response to low or high doses of infection [36]. It was, therefore, very difficult if not impossible to directly compare results from these different studies.
###end p 62
###begin p 63
###xml 110 123 110 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pneumoniae</italic>
###xml 285 289 285 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-McAuley1">[39]</xref>
###xml 475 479 475 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-Tettelin1">[27]</xref>
###xml 684 690 684 690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004840-g002">Fig. 2</xref>
###xml 857 864 857 864 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004840-g004">Figs. 4</xref>
###xml 865 865 865 865 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004840-g005"/>
###xml 865 866 865 866 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004840-g006">6</xref>
###xml 102 105 <span type="species:ncbi:11320">IAV</span>
###xml 110 123 <span type="species:ncbi:1313">S. pneumoniae</span>
###xml 192 197 <span type="species:ncbi:10090">mouse</span>
###xml 262 265 <span type="species:ncbi:11320">IAV</span>
###xml 280 284 <span type="species:ncbi:10090">mice</span>
###xml 375 380 <span type="species:ncbi:10090">mouse</span>
###xml 559 562 <span type="species:ncbi:11320">IAV</span>
Thus it was necessary to investigate leukocyte numbers and susceptibility for synergistic function of IAV and S. pneumoniae in a controlled system simultaneously. We used the well established mouse adapted viral strain PR8/A/34 which is widely used for studying IAV infections in mice [39]. This was combined with the pneumococcal strain TIGR4, which is highly invasive in a mouse model and has been sequenced, thus can be considered a molecularly defined reference pathogen [27]. Our data for the first time show, that highly efficient synergistic action of IAV and pneumococcal infection can occur in the presence of normal or even increased numbers of peripheral blood leukocytes (Fig. 2). We further demonstrate that a forced reduction of peripheral leukocytes does not predispose for pneumococcal infection, at least in the model system analyzed here (Figs. 4-6).
###end p 63
###begin p 64
###xml 250 254 250 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-Sun1">[19]</xref>
###xml 306 310 306 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-Tateda1">[40]</xref>
###xml 508 515 508 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004840-g004">Fig. 4A</xref>
###xml 520 524 520 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-Gunzer1">[26]</xref>
###xml 628 632 628 632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-Gunzer1">[26]</xref>
###xml 816 820 816 820 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-Kadioglu2">[14]</xref>
###xml 822 826 822 826 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-Kadioglu3">[16]</xref>
###xml 918 925 918 925 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004840-g006">Fig. 6A</xref>
###xml 1279 1300 1279 1300 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Aspergillus fumigatus</italic>
###xml 1437 1450 1437 1450 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pneumoniae</italic>
###xml 1187 1191 <span type="species:ncbi:10090">mice</span>
###xml 1225 1229 <span type="species:ncbi:10090">mice</span>
###xml 1279 1300 <span type="species:ncbi:5085">Aspergillus fumigatus</span>
###xml 1437 1450 <span type="species:ncbi:1313">S. pneumoniae</span>
This might point to the fact that neither PMN nor lymphocytes are necessary in the early phase of the response to this bacterial infection. Indeed, lung-resident alveolar macrophages are the first line of cellular defence for pneumococcal infections [19] and these are not depleted by the antibody RB6-8C5 [40] and most likely also not by TLR7 triggering. In addition, the lymphopenic phase after R-848-treatment is transient. Lymphocyte levels are back to normal or even higher 48 h after R-848 triggering (Fig. 4A and [26]). This time window of absence is long enough to inhibit acute responses from primed peripheral T cells [26] but obviously not sufficiently long to inhibit the protective impact of polyclonal CD4 cells on the outcome of a pneumococcal threat, which has been observed in CD4 deficient animals [14], [16]. However, PMN numbers are almost undetectable for up to 5 days after injection of RB6-8C5 (Fig. 6A), which is mirrored at the site of infection 24 h post injection, thus making a significant contribution of PMN for pneumococcal resistance in this model unlikely. Removal of PMN by a single injection of RB6-8C5 induces a profound immune suppression in C57Bl/6 mice rendering the normally resistant mice highly susceptible to a pulmonary infection with Aspergillus fumigatus (data not shown). But the same degree of immune suppression seems not sufficient to mediate increased susceptibility for infection with S. pneumoniae.
###end p 64
###begin p 65
###xml 446 450 442 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-Sun1">[19]</xref>
###xml 620 624 612 616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-Sun2">[33]</xref>
###xml 893 897 885 889 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-Sun1">[19]</xref>
###xml 905 909 897 901 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-Didierlaurent1">[18]</xref>
###xml 911 915 903 907 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-Navarini1">[22]</xref>
###xml 1124 1128 1116 1120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-Speshock1">[17]</xref>
###xml 1130 1134 1122 1126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-McAuley1">[39]</xref>
###xml 1281 1285 1273 1277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-McAuley1">[39]</xref>
###xml 1397 1401 1389 1393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-Kobasa1">[41]</xref>
###xml 1467 1471 1459 1463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-Kobasa2">[42]</xref>
###xml 1473 1477 1465 1469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-Kash1">[43]</xref>
###xml 1173 1176 <span type="species:ncbi:11320">IAV</span>
###xml 1296 1299 <span type="species:ncbi:11320">IAV</span>
###xml 1414 1419 <span type="species:ncbi:9606">human</span>
###xml 1462 1466 <span type="species:ncbi:10090">mice</span>
Our study now firmly establishes, that normal numbers of circulating leukocytes do not protect from a lethal bacterial superinfection but that the lack of peripheral leukocytes alone does not predispose for the infection. What might be the reason for this phenomenon? Recent evidence suggests, that Interferon-gamma produced massively by the immune system during viral defence renders alveolar macrophages unable to phagocytose incoming bacteria [19]. However, a previous paper from the same group finds, that Interferon-gamma-mediated recruitment of PMN to the lung is a protective mechanism for pneumococcal infection [33], calling the importance of the other finding for pneumococcal susceptibility into question. Nevertheless, these results belong to a group of observations that link the natural antiviral response with a toxic impact on endogenous immune cells like alveolar macrophages [19] or PMN [18], [22]. A different line of findings demonstrates that an overt immune response, mainly of PMN origin, is responsible for a pathologic destruction of lung tissue in the attempt to fight the bacterial superinfection [17], [39]. This has recently been linked to the IAV-protein PB1-F2 with the 1918-strain being the source of a particularly virulent version of this protein [39]. However, IAV-1918 is special leading to an uncontrolled and not well timed cytokine storm in infected animals [41] making this human-adapted strain also highly pathogenic for mice [42], [43].
###end p 65
###begin p 66
###xml 209 215 209 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004840-g001">Fig. 1</xref>
###xml 486 492 486 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004840-g002">Fig. 2</xref>
###xml 494 495 494 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004840-g004">4</xref>
###xml 496 496 496 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004840-g005"/>
###xml 496 497 496 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004840-g006">6</xref>
###xml 811 815 811 815 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-Marks1">[44]</xref>
###xml 986 990 986 990 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004840-McCullers3">[45]</xref>
###xml 234 238 <span type="species:ncbi:10090">mice</span>
###xml 345 348 <span type="species:ncbi:11320">IAV</span>
###xml 546 550 <span type="species:ncbi:10090">mice</span>
###xml 773 778 <span type="species:ncbi:10090">mouse</span>
###xml 889 892 <span type="species:ncbi:11320">IAV</span>
However, these findings can only partially explain the processes in co-infected animals in the model used here. We have used the viral strain PR8/A/34 leading to a relatively mild form of the viral infection (Fig. 1). The majority of mice can cope well with the infection and clear it without a large health burden which is in sharp contrast to IAV-1918. What causes increased superinfection here must remain open. Our data show that depletion of peripheral leukocytes is not critical (Fig. 2, 4-6). In contrast, analyses of BAL from co-infected mice in our model suggest a highly increased infiltration of the lung with PBMC (data not shown). Unable to protect from superinfection, these cells could even be toxic and their depletion might result in a health benefit in a mouse model of pneumococcal infection [44]. If this can be further substantiated, it might be considered for future IAV epidemics to combine a prophylactic antibiotic treatment, which on its own is not protective [45] with some form of medical control for overt leukocyte recruitment and the uncontrolled release of pro-inflammatory cytokines.
###end p 66
###begin p 67
We thank Mike Hasenberg for help with the PMN depletion experiment.
###end p 67
###begin title 68
References
###end title 68
###begin article-title 69
Influenza and the challenge for immunology.
###end article-title 69
###begin article-title 70
Scientific barriers to developing vaccines against avian influenza viruses.
###end article-title 70
###begin article-title 71
1918 Influenza: the mother of all pandemics.
###end article-title 71
###begin article-title 72
Characterization of the 1918 influenza virus polymerase genes.
###end article-title 72
###begin article-title 73
Characterization of the reconstructed 1918 Spanish influenza pandemic virus.
###end article-title 73
###begin article-title 74
Lessons learned from reconstructing the 1918 influenza pandemic.
###end article-title 74
###begin article-title 75
Insights into the interaction between influenza virus and pneumococcus.
###end article-title 75
###begin article-title 76
Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness.
###end article-title 76
###begin article-title 77
###xml 11 35 <span type="species:ncbi:1313">Streptococcus pneumoniae</span>
A role for Streptococcus pneumoniae in virus-associated pneumonia.
###end article-title 77
###begin article-title 78
###xml 45 69 <span type="species:ncbi:1313">Streptococcus pneumoniae</span>
###xml 93 98 <span type="species:ncbi:10090">mouse</span>
Lethal synergism between influenza virus and Streptococcus pneumoniae: characterization of a mouse model and the role of platelet-activating factor receptor.
###end article-title 78
###begin article-title 79
The innate immune response to pneumococcal lung infection: the untold story.
###end article-title 79
###begin article-title 80
Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines.
###end article-title 80
###begin article-title 81
Early predictors of mortality in pneumococcal bacteraemia.
###end article-title 81
###begin article-title 82
###xml 12 36 <span type="species:ncbi:1313">Streptococcus pneumoniae</span>
The role of Streptococcus pneumoniae virulence factors in host respiratory colonization and disease.
###end article-title 82
###begin article-title 83
Innate immunity and the pneumococcus.
###end article-title 83
###begin article-title 84
CD4-T-lymphocyte interactions with pneumolysin and pneumococci suggest a crucial protective role in the host response to pneumococcal infection.
###end article-title 84
###begin article-title 85
###xml 12 29 <span type="species:ncbi:11320">influenza A virus</span>
###xml 52 56 <span type="species:ncbi:10090">mice</span>
###xml 107 131 <span type="species:ncbi:1313">Streptococcus pneumoniae</span>
Filamentous influenza A virus infection predisposes mice to fatal septicemia following superinfection with Streptococcus pneumoniae serotype 3.
###end article-title 85
###begin article-title 86
Sustained desensitization to bacterial Toll-like receptor ligands after resolution of respiratory influenza infection.
###end article-title 86
###begin article-title 87
Inhibition of pulmonary antibacterial defense by interferon-gamma during recovery from influenza infection.
###end article-title 87
###begin article-title 88
###xml 63 67 <span type="species:ncbi:10090">mice</span>
###xml 139 145 <span type="species:ncbi:9606">humans</span>
Depletion of lymphocytes and diminished cytokine production in mice infected with a highly virulent influenza A (H5N1) virus isolated from humans.
###end article-title 88
###begin article-title 89
Type I interferons directly regulate lymphocyte recirculation and cause transient blood lymphopenia.
###end article-title 89
###begin article-title 90
Increased susceptibility to bacterial superinfection as a consequence of innate antiviral responses.
###end article-title 90
###begin article-title 91
Innate Antiviral Responses by Means of TLR7-Mediated Recognition of Single-Stranded RNA.
###end article-title 91
###begin article-title 92
Species-Specific Recognition of Single-Stranded RNA via Toll-like Receptor 7 and 8.
###end article-title 92
###begin article-title 93
RIG-I-Mediated Antiviral Responses to Single-Stranded RNA Bearing 5' Phosphates.
###end article-title 93
###begin article-title 94
Systemic administration of a TLR7 ligand leads to transient immune incompetence due to peripheral blood leukocyte depletion.
###end article-title 94
###begin article-title 95
###xml 50 74 <span type="species:ncbi:1313">Streptococcus pneumoniae</span>
Complete genome sequence of a virulent isolate of Streptococcus pneumoniae.
###end article-title 95
###begin article-title 96
###xml 13 17 <span type="species:ncbi:10090">mice</span>
###xml 88 94 <span type="species:ncbi:9606">humans</span>
Virulence in mice of pneumococcal clonal types with known invasive disease potential in humans.
###end article-title 96
###begin article-title 97
A study of the genetic material determining an enzyme in Pneumococcus.
###end article-title 97
###begin article-title 98
A simple method of estimating fifty percent endpoints.
###end article-title 98
###begin article-title 99
###xml 65 71 <span type="species:ncbi:10090">murine</span>
Characterization and regulation of RB6-8C5 antigen expression on murine bone marrow cells.
###end article-title 99
###begin article-title 100
Neutrophils are essential for early anti-Listeria defense in the liver, but not in the spleen or peritoneal cavity, as revealed by a granulocyte-depleting monoclonal antibody.
###end article-title 100
###begin article-title 101
###xml 130 154 <span type="species:ncbi:1313">Streptococcus pneumoniae</span>
Interleukin-12 promotes gamma interferon-dependent neutrophil recruitment in the lung and improves protection against respiratory Streptococcus pneumoniae infection.
###end article-title 101
###begin article-title 102
###xml 169 175 <span type="species:ncbi:10090">murine</span>
Differential contribution of bacterial N-formyl-methionyl-leucyl- phenylalanine and host-derived CXC chemokines to neutrophil infiltration into pulmonary alveoli during murine pneumococcal pneumonia.
###end article-title 102
###begin article-title 103
###xml 138 162 <span type="species:ncbi:1313">Streptococcus pneumoniae</span>
Both influenza-induced neutrophil dysfunction and neutrophil-independent mechanisms contribute to increased susceptibility to a secondary Streptococcus pneumoniae infection.
###end article-title 103
###begin article-title 104
Genetic background affects susceptibility in nonfatal pneumococcal bronchopneumonia.
###end article-title 104
###begin article-title 105
###xml 56 80 <span type="species:ncbi:1313">Streptococcus pneumoniae</span>
###xml 84 88 <span type="species:ncbi:10090">mice</span>
A major locus conferring susceptibility to infection by Streptococcus pneumoniae in mice.
###end article-title 105
###begin article-title 106
###xml 131 136 <span type="species:ncbi:10090">mouse</span>
Role of genetic resistance in invasive pneumococcal infection: identification and study of susceptibility and resistance in inbred mouse strains.
###end article-title 106
###begin article-title 107
###xml 23 40 <span type="species:ncbi:11320">influenza A virus</span>
Expression of the 1918 influenza A virus PB1-F2 enhances the pathogenesis of viral and secondary bacterial pneumonia.
###end article-title 107
###begin article-title 108
###xml 81 87 <span type="species:ncbi:10090">murine</span>
###xml 97 119 <span type="species:ncbi:446">Legionella pneumophila</span>
Early recruitment of neutrophils determines subsequent T1/T2 host responses in a murine model of Legionella pneumophila pneumonia.
###end article-title 108
###begin article-title 109
Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus.
###end article-title 109
###begin article-title 110
Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus.
###end article-title 110
###begin article-title 111
Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virus.
###end article-title 111
###begin article-title 112
###xml 79 83 <span type="species:ncbi:10090">mice</span>
Influence of neutropenia on the course of serotype 8 pneumococcal pneumonia in mice.
###end article-title 112
###begin article-title 113
Effect of antiviral treatment on the outcome of secondary bacterial pneumonia after influenza.
###end article-title 113
###begin p 114
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 114
###begin p 115
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by the International Research Training Group 1273 funded by the German Research Foundation (DFG) and by grants from the Deutsche Forschungsgemeinschaft to M. Gunzer. and B.H-N, the Torsten och Ragnar Soederbergs Foundation and the Swedish Research Council to B.H-N and the DFG (SFB 587) to D.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 115

